Society guideline links: Insomnia in adults

Introduction — 

This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Insomnia in children" and "Society guideline links: Parasomnias, hypersomnias, and circadian rhythm disorders" and "Society guideline links: Restless legs syndrome".)

International

●World Sleep Society (WSS): Endorsement of European guideline for the diagnosis and treatment of insomnia (2021)

●Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia – Evidence-based clinical practice guideline (2018)

Canada

●Choosing Wisely Canada: Don't routinely prescribe benzodiazepines or other sedative-hypnotics for promotion of sleep without first a trial of non-pharmacologic interventions (updated 2024)

●Choosing Wisely Canada: Don't use benzodiazepines and other sedative-hypnotics in older adults as first choice for insomnia, agitation or delirium (updated 2024)

●Choosing Wisely Canada: Question the use of antipsychotics to treat insomnia in any age group (updated 2024)

United States

●Department of Veterans Affairs (VA)/Department of Defense (DoD): Clinical practice guideline for the management of chronic insomnia disorder and obstructive sleep apnea (2025)

●Society of Anesthesia and Sleep Medicine (SASM): Position paper on patient sleep during hospitalization (2023)

●American Academy of Sleep Medicine (AASM): Clinical practice guideline on behavioral and psychological treatments for chronic insomnia disorder in adults (2021)

●AASM: Clinical practice guideline for the use of actigraphy for the evaluation of sleep disorders and circadian rhythm sleep-wake disorders (2018)

●AASM: Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults (2017)

●AASM and Sleep Research Society (SRS): Joint consensus statement on the recommended amount of sleep for a healthy adult (2015)

●American Thoracic Society (ATS): An official statement on the importance of healthy sleep – Recommendations and future priorities (2015)

●AASM: Clinical guideline for the evaluation and management of chronic insomnia in adults (2008)

Europe

●European Sleep Research Society (ESRS) and European Insomnia Network (EIN): The European insomnia guideline on the diagnosis and treatment of insomnia, update (2023)

●European Academy of Neurology (EAN)/European Respiratory Society (ERS)/European Stroke Organization (ESO)/ESRS: Statement on the impact of sleep disorders on risk and outcome of stroke (2020)

United Kingdom

●National Institute for Health and Care Excellence (NICE): Medical technologies guidance on Sleepio to treat insomnia and insomnia symptoms (2022)

●British Association for Psychopharmacology (BAP): Consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders, update (2019)

Australia–New Zealand

●Australasian Sleep Association (ASA): Position statement regarding the use of psychological/behavioral treatments in the management of insomnia in adults (2017)

●Choosing Wisely Australia: Do not prescribe benzodiazepines or other sedative-hypnotics to older adults as first choice for insomnia, agitation or delirium (2016)

Japan

●[In Japanese] Choosing Wisely Japan: Treating sleep disorders – Antipsychotics not always best (2016)